Cargando…
Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era
In recent years the global market for monoclonal antibodies (mAbs) became a multi-billion-dollar business. This success is mainly driven by treatments in the oncology and autoimmune space. Instead, development of effective mAbs against infectious diseases has been lagging behind. For years the high...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670927/ https://www.ncbi.nlm.nih.gov/pubmed/33277154 http://dx.doi.org/10.1016/j.smim.2020.101427 |